Jafron BiomedicalLtd Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Fan Dong

Geschäftsführender

CN¥3.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer14.2yrs
Eigentum des Geschäftsführers45.9%
Durchschnittliche Amtszeit des Managements1.9yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder3.4yrs

Jüngste Management Updates

Recent updates

Earnings Report: Jafron Biomedical Co.,Ltd. Missed Revenue Estimates By 8.1%

Oct 21
Earnings Report: Jafron Biomedical Co.,Ltd. Missed Revenue Estimates By 8.1%

Further Upside For Jafron Biomedical Co.,Ltd. (SZSE:300529) Shares Could Introduce Price Risks After 34% Bounce

Oct 02
Further Upside For Jafron Biomedical Co.,Ltd. (SZSE:300529) Shares Could Introduce Price Risks After 34% Bounce

Estimating The Fair Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

Sep 09
Estimating The Fair Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

The Returns On Capital At Jafron BiomedicalLtd (SZSE:300529) Don't Inspire Confidence

Aug 25
The Returns On Capital At Jafron BiomedicalLtd (SZSE:300529) Don't Inspire Confidence

Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

May 28
Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

May 24
A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

May 08
Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

May 02
Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Apr 13
Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Mar 22
Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

Mar 04
Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

Geschäftsführer

Fan Dong (54 yo)

14.2yrs

Amtszeit

CN¥3,741,000

Vergütung

Mr. Fan Dong serves as Chairman of Board of Directors and General Manager at Jafron Biomedical Co., Ltd. He serves as Director since April 27, 2023 at Jafron Biomedical Co.,Ltd. He served as Company Secret...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Fan Dong
Chairman of Board of Directors & GMno dataCN¥3.74m45.86%
CN¥ 10.9b
Xueyun Liao
Director & Financial Director1.6yrsCN¥500.50k0.019%
CN¥ 4.5m
De Zhi Li
Deputy General Managerno dataCN¥865.40k0.46%
CN¥ 108.4m
Xian Min Tang
Deputy GM & Directorno dataCN¥2.65m2.76%
CN¥ 653.1m
Aijun Wu
Deputy General Manager4.5yrsCN¥2.44m0.031%
CN¥ 7.4m
Rui Wang
General Manager1.2yrsCN¥510.40kkeine Daten
Cong Huang
Board Secretary2.2yrsCN¥455.20k0.00044%
CN¥ 104.3k

1.9yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrenes Management: 300529Das Führungsteam des Unternehmens gilt nicht als erfahren ( 1.9 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Fan Dong
Chairman of Board of Directors & GM14.2yrsCN¥3.74m45.86%
CN¥ 10.9b
Xueyun Liao
Director & Financial Directorless than a yearCN¥500.50k0.019%
CN¥ 4.5m
Xian Min Tang
Deputy GM & Director14.2yrsCN¥2.65m2.76%
CN¥ 653.1m
Claudio Ronco
Member of Global Advisory Board3.4yrskeine Datenkeine Daten
Feng Li
Non-Independent Director4.6yrsCN¥1.08m0.099%
CN¥ 23.4m
Xiaohong Peng
Chairman of Supervisory Board4.6yrskeine Datenkeine Daten
Wen Lei
Non-Independent Director4.6yrsCN¥177.20kkeine Daten
Rinaldo Bellomo
Member of Global Advisory Board3.4yrskeine Datenkeine Daten
Thomas Rimmelé
Member of Global Advisory Board3.4yrskeine Datenkeine Daten
John Prowle
Member of Global Advisory Board3.4yrskeine Datenkeine Daten
Antoine Schneider
Member of Global Advisory Board3.4yrskeine Datenkeine Daten
Olivier Joannes-Boyau
Member of Global Advisory Board3.4yrskeine Datenkeine Daten

3.4yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrener Vorstand: 300529Die Vorstandsmitglieder gelten als erfahren (3.4 Jahre durchschnittliche Amtszeit).